Combined Radioimmunotherapy and Radiotherapy of Human Colon Carcinoma Grafted in Nude Mice

Cancer Research

Volumn 55, Issue 1, 1995, Pages 83-89

  Buchegger, Franz ^a   Rojas, Anamaria ^b   Delaloye, Angelika Bischof ^a   Vogel, Charles André ^a   Mirimanoff, René Olivier ^a   Coucke, Philippe ^a   Sun, Lin Quan ^a   Raimondi, Serge ^a   Denekamp, Julie ^b   Pèlegrin, André ^c   Delaloye, Bernard ^a   Mach, Jean Pierre ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IODINE 131;

ANIMAL MODEL; ARTICLE; BEAM THERAPY; BONE MARROW DEPRESSION; CANCER GRAFT; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SKIN TOXICITY; TUMOR VOLUME;

ANIMAL; ANTIBODIES, MONOCLONAL; BLOOD; BONE MARROW; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMAN; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; SKIN DISEASES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0028898454     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Suit, H. D. Local control and patient survival. Int. J. Radiat. Oncol. Biol. Phys., 23: 653–660, 1992.
2. Order, S. E., Klein, J. L., Leichner, P. K., and Ettinger, D. S. Hepatoma: model for radiolabeled antibody in cancer treatment. Natl. Cancer Inst. Monogr., 3: 37–41, 1987.
3. Mach, J-P., Pèlegrin, A., and Buchegger, F. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr. Opin. Immunol., 3: 685–693, 1991.
4. Scheinberg, D. A. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers. Curr. Opin. Immunol., 3: 679–684, 1991.
5. Goldenberg, D. M., and Schlom, J. The coming of age of cancer radioimmunoconjugates. Immunol. Today, 14: 5–7, 1993.
6. Folli, S., Wagnières, G., Pèlegrin, A., et al. Localization and detection of fluores-ceinated chimeric antibodies against carcinoembryonic antigen in primary colorectal carcinomas: first approach to clinical immunophotodiagnosis. Proc. Natl. Acad. Sci. USA, 89: 7973–7977, 1992.
7. Breitz, H. B., Weiden, P. L., Vanderheyden, J-L., et al. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. J. Nucl. Med., 33: 1099–1112, 1992.
8. Chatal, J-F., Saccavini, J-C., Gestin, J-F., Thédrez, P., Curtet, C., Kremer, M., Guerreau, D., Nolibé, D., Fumoleau, P., and Guillard, Y. Biodistribution of indium-111-labeled OC125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res., 49: 3087–3094, 1989.
9. Sheldon, P. W., and Hill, S. A. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br. J. Cancer, 35: 795–808, 1977.
10. Wessels, B. W., and Griffith, M. H. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models. J. Nucl. Med., 27: 1308–1314, 1986.
11. Yorke, E. D., Williams, L. E., Demidecki, A. J., Heidorn, D. B., Roberson, P. L., and Wessels, B. W. Multicellular dosimetry for beta-emitting radionuclides: autoradiography thermoluminescent dosimetry and three-dimensional dose calculations. Med. Phys. (NY), 20: 543–550, 1993.
12. 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab′)2 fragments. J. Clin. Invest., 83: 1449–1456, 1989.
13. Hammarstrom, S., Shively, J. E., Paxton, R. J., et al. Antigenic sites in carcinoembryonic antigen. Cancer Res, 49: 4852–4858, 1989.
14. Buchegger, F., Schreyer, M., Carrel, S., and Mach, J-P. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int. J. Cancer, 33: 643–649, 1984.
15. Audette, M., Buchegger, F., Schreyer, M., and Mach, J-P. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Mol. Immunol., 24: 1177–1186, 1987.
16. Nap, M., Hammarström, M. L., Bonner, O., et al Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res., 52: 2329–2339, 1992.
17. 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int. J. Cancer, 41: 127–134, 1988.
18. Vogel, C. A., Bischof Delaloye, A., Mach, J-P., Pèlegrin, A., Hardman, N., Delaloye, B., and Buchegger, F. Direct comparison of a radioiodinated intact chimeric anti-CEA Mab with its F(ab′)2 fragment in nude mice bearing different colon cancer xenografts. Br. J. Cancer, 68: 684–690, 1993.
19. Johns, H., and Joiner, M. C. A simple method for fitting curves to dose-effect data for functional damage. Int. J. Radiat. Biol., 60: 533–541, 1991.
20. 131I labeled F(ab′)2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med., 31: 1035–1044, 1990.
21. Okunieff, P., Dols, S., Lee, J., Singer, S., Vaupel, P., Neuringer, L. J., and Beshah, K. Angiogenesis determines blood flow, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonsnee studies. Cancer Res., 51: 3289–3295, 1991.
22. Hagan, P. L., Halpern, S. E., Dillman, R. O., et al Tumor size: effect on monoclonal antibody uptake in tumor models. J. Nucl. Med., 27: 422–427, 1986.
23. Buchsbaum, D. J., and Wessels, B. W. Radiolabeled antibody tumor dosimetry. Med. Phys. (NY), 20: 499–501, 1993.
24. Buchegger, F., Haskell, C. M., Schreyer, M., Scazziga, B. R., Randin, S., Carrel, S., and Mach, J-P. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J. Exp. Med., 158: 413–427, 1983.
25. Sutherland, R., Buchegger, F., Schreyer, M., Vacca, A., and Mach, J-P. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res., 47: 1627–1633, 1987.
26. Jain, R. K. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res., 50: 814s-819s, 1990.
27. Baxter, L. T., Zhu, H., Mackensen, D. G., and Jain, R. K. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res., 54: 1517–1528, 1994.
28. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors:a review. Cancer Res., 49:6449–6465, 1989.
29. Folli, S., Pèlegrin, A., Chalandon, Y., Yo, X., Buchegger, F., Lejeune, F., and Mach, J-P. Tumor necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by selective increase of vascular permeability. Int. J. Cancer, 53:829–836, 1993.
30. Wessels, B. W., Vessella, R. L., Palme, 1.1., D. F., Berkopec, J. M., Smith, G. K., and Bradley, E. W. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts. Int. J. Radiat. Oncol. Biol. Phys., 17:1257–1263, 1989.
31. Buras, R. R., Wong, J. Y. C., Kuhn, J. A., Beatty, B. G., Williams, L. E., Wanek, P. M., and Beatty, J. D. Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts. Int. J. Radiat. Oncol. Biol. Phys., 25:473–479, 1992.
32. Williams, J. A., Edwards, J. A., and Dillehay, L. E. Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts. Int. J. Radiat. Oncol. Biol. Phys., 24:111–117, 1992.
33. Knox, S. J., Goris, M. L., and Wessels, B. W. Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother. Oncol., 23:111–117, 1992.
34. Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., and Wesson, M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys., 21:109–122, 1991.
35. Burman, C., Kutcher, G. J., Emami, B., and Goitein, M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys., 21:123–135, 1991.
36. Humm, J. L. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med., 27:1490–1497, 1986.
37. Fowler, J. F. Radiobiological aspects of low dose rates in radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys., 18:1261–1269, 1990.
38. Moulder, J. E., Fish, B. L., and Wilson, J. F. Tumor and normal tissue tolerance for fractionated low-dose-rate radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 19:341–348, 1990.
39. Turesson, I. Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation. Radiother. Oncol., 19:1–16, 1990.
40. Williams, J. R., Zhang, Y-G., and Dillehay, L. E. Sensitization processes in human tumor cells during protacted irradiation:possible exploitation in the clinic. Int. J. Radiat. Oncol. Biol. Phys., 24:699–704, 1992.
41. Lambin, P., Marples, B., Fertil, B., Malaise, E. P., and Joiner, M-C. Hypersensitivity of a human tumour cell line to very low radiation doses. Int. J. Radiat. Biol., 63:639–650, 1993.
42. Langmuir, V. K., Fowler, J. F., Knox, S. J., Wessels, B. W., Sutherland, R. M., and Wong, J. Y. C. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. Med. Phys. (NY), 20:601–610, 1993.
43. Kalofonos, H., Rowlinson, G., and Epenetos, A. A. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res., 50:159–163, 1990.